David Meeker - President and CEO, Rhythm Pharmaceuticals, Inc
As of March 31, 2021
David Meeker Net Worth
- Net worth is estimated to be at least $1.87M
- Owns at least 111,335 units of Rhythm Pharmaceuticals, Inc stock
David Meeker Compensation at Rhythm Pharmaceuticals, Inc in 2020
- Earned a $262,308 salary
- Rewarded $918,500 in stock value and options
- Received a total compensation of $13,358,867
David Meeker Trading
- Largest purchase of shares was 79,525 units , worth over $425K on October 10, 2017
- In total has made about 7 transactions over 4 years
- Usually trades in June, with the busiest year in 2020 and 2021
David P Meeker
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
David Meeker Mailing Address
- Mailing address is C/o Penwest Pharmaceuticals Co 39 Old Ridgebury Road Suite 11 Danbury CT 06810 CT
Rhythm Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|---|---|
David P. Meeker, M.D. | 2020 | $262,308 | - | $918,500 | $12,844,897 | $207,958 | $43,704 | $13,358,867 |
Keith M. Gottesdiener, M.D. | 2020 | $142,906 | - | - | $2,810,726 | - | $495,537 | $3,449,169 |
Keith M. Gottesdiener, M.D. | 2019 | $525,934 | - | - | $4,133,768 | $277,340 | - | $4,937,042 |
Hunter C. Smith | 2020 | $416,118 | $60,000 | $132,000 | $1,837,630 | $209,595 | $7,125 | $2,530,468 |
Hunter C. Smith | 2019 | $396,992 | - | - | $1,286,061 | $153,224 | $86,576 | $1,922,853 |
Murray Stewart, D.M., F.R.C.P. | 2020 | $451,169 | $60,000 | $113,000 | $1,555,420 | $226,600 | $7,125 | $2,300,314 |
Jennifer Chien | 2020 | $45,577 | $100,000 | $100,000 | $1,517,540 | $49,375 | - | $1,712,492 |
Nithya Desikan | 2020 | $305,510 | - | $105,000 | $1,533,841 | - | $104,620 | $1,943,971 |
Nithya Desikan | 2019 | $379,063 | - | - | $1,286,061 | $145,117 | - | $1,810,241 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1649904/000110465921055591/tm212464-1_def14a.htm
Rhythm Pharmaceuticals, Inc Insider Trading
- The most recent transaction was 1,023 units sold on March 31, 2022 by William T Roberts worth over $11.39K
- In the last 5 years, insiders at Rhythm Pharmaceuticals, Inc sold an estimated value of $75.41M and bought an estimated value of $108.59M
- The most active traders are Todd Foley, Director, Keith M. Gottesdiener, CEO & President, and Hunter C Smith, Chief Financial Officer
- Insider trading is most common in February, with the busiest year in 2020
RHYTHM PHARMACEUTICALS, INC. Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |